Trial intelligence / Profile preview

Besifloxacin vs Gatifloxacin for Bacterial Conjunctivitis in Neonates

NCT01330355Phase 3Terminated

Sponsor
Bausch + Lomb
Start
May 2011
Primary completion
Jan 2013
Countries
1
01

Overview

A Phase 3 trial of Besifloxacin ophthalmic suspension vehicle in bacterial conjunctivitis (BC), sponsored by Bausch + Lomb. Started May 2011; status: terminated.

02

Drugs

Besifloxacin ophthalmic suspension vehicle
03

Conditions

bacterial conjunctivitis (BC)

Beyond the preview

Go deeper on NCT01330355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01330355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call